Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke. - Wikidata - awgldk - TriplyDB

Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.

Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.

http://www.wikidata.org/entity/Q37158146

about

Regulatory T cell in stroke: a new paradigm for immune regulation Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair How and why do T cells and their derived cytokines affect the injured and healthy brain?Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease.Transient decrease in circulating dendritic cell precursors after acute stroke: potential recruitment into the brain.Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair Long term immunologic consequences of experimental stroke and mucosal tolerance.Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke.Plasma α-melanocyte stimulating hormone predicts outcome in ischemic stroke.Autoimmune responses to brain following stroke.Activation of immune responses to brain antigens after stroke.Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS?CNS immune responses following experimental stroke The Immune Response to Acute Focal Cerebral Ischemia and Associated Post-stroke Immunodepression: A Focused Review.Modulation of the postischemic immune response to improve stroke outcome.Anamnestic recall of stroke-related deficits: an animal model.α-MSH: a potential neuroprotective and immunomodulatory agent for the treatment of stroke.Autoimmune responses to the brain after stroke are associated with worse outcome.Functional role of regulatory lymphocytes in stroke: facts and controversies.Myelin specific cells infiltrate MCAO lesions and exacerbate stroke severity.Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia.Effect of Inducible Co-Stimulatory Molecule siRNA in Cerebral Infarction Rat Models Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO.Reduced Numbers and Impaired Function of Regulatory T Cells in Peripheral Blood of Ischemic Stroke Patients.Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.Mucosal tolerance to E-selectin promotes the survival of newly generated neuroblasts via regulatory T-cell induction after stroke in spontaneously hypertensive rats.Sensitization and tolerization to brain antigens in stroke.Recombinant T cell receptor ligand treats experimental stroke.The immunologic profile of adoptively transferred lymphocytes influences stroke outcome of recipients.mTOR regulates neuroprotective effect of immunized CD4+Foxp3+ T cells in optic nerve ischemia.Sterile inflammation after permanent distal MCA occlusion in hypertensive rats.Ischemic tolerance in the brain: endogenous adaptive machinery against ischemic stress.The immunology of acute stroke.Regulatory T Cells in Post-stroke Immune Homeostasis.The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso-occlusive crises.Antigen Presentation After Stroke.Promiscuity of autoimmune responses to MBP after stroke.Treatment of surgical brain injury by immune tolerance induced by intrathymic and hepatic portal vein injection of brain antigens.The privileged immunity of immune privileged organs: the case of the eye.Preoperative mucosal tolerance to brain antigens and a neuroprotective immune response following surgical brain injury.

P2860

Q26995751-E9C7D08A-2A43-40B6-81AF-9B3FEF47424A Q28078211-6E4695AA-0102-4CE7-96D2-450A9D0F1061 Q30252510-E03DB52C-96AB-40F3-89E4-85BA3933666D Q30493249-5D030BF4-2353-40B6-85C2-44FA57B5F31B Q33464564-BC62BFD2-73E4-4BE1-B7C5-0A33D09571AD Q33583258-40AAA8CB-3A4D-4AE8-8987-389E3885AF30 Q33631679-C1676FC5-315F-493B-A36D-374C95A2076A Q34024724-B555F8E4-87A1-4D77-8BE2-EFE2EBAA500A Q34049621-50C9B1BE-648B-486D-ACF4-A91B6EECB2A3 Q34049644-F197A374-4E0F-4CD3-9B0F-408477868E67 Q34069139-2CFB8D94-9CCE-4E00-832A-FD46A9A3DC06 Q34219556-48E9F19F-9CAF-47C9-AAD5-1D54817CAE6C Q34232353-6C54C335-FBA4-47D4-8600-1B149FD672F5 Q34237954-FAF94E87-7AA6-4D97-90AB-60D227568AC0 Q34238350-233EF7ED-2F35-4145-9032-2B25DDF0C77A Q34473891-B39D17FF-A560-4A2E-8574-3F5DC63B9DFE Q34627621-A5213637-2E3D-4231-9AA1-031C0E9B2739 Q35243961-44F865CA-9901-41EE-AAA5-1E7ECA033DAC Q35554595-58AB0187-F685-4C78-A114-08C7583D3A4F Q35722702-2C9A2523-3A15-466A-9311-CC896C0DF3DE Q35866882-507E108F-31E4-4BA6-973A-75BA5BC6619B Q36140518-5A40F7C1-9ED4-4F7C-A2A5-BC2D3CDA41A0 Q36684202-4B1869AE-0F42-47FE-84A3-83416B3C6453 Q36747688-66E92665-3288-4A25-9B1D-48D1EE97B52C Q37158226-A75C1C19-266D-4D05-B9FA-6E2710318E77 Q37216701-B2DD93D9-2679-4452-B144-B2014018D9EF Q37244830-8C588A39-1F6B-461C-B1EB-75A9F66562CB Q37246578-8B9105EC-D342-4312-A9C6-F1BC0115EB8B Q37339885-A9F75DB9-7EEC-43FB-8288-85DFEEC17E0E Q37439191-5EEA8B4C-B649-4B6D-9E4F-AA8E9645F99D Q37559334-A1B7A80C-A821-4BEF-8C1C-8C0A9CF3A096 Q37981130-E0B093F7-C23E-4FAC-AD3A-F9C0572477E9 Q38016069-5BBB5ECA-96A0-4466-810B-BE58C78BEF09 Q38794156-5694EC72-29F0-42D0-AF78-9F0D376C068D Q38853641-44FE7969-5D84-4C8D-96CB-77C81147A075 Q38925065-A3C5C7D2-D90E-4254-B7D4-8ED1A69B6FF8 Q40710496-357EFA45-58BE-40D4-91C3-899BA671060C Q41329269-D40345B7-6DF0-4AED-9791-EA809C0A3EDA Q42326687-B7EC9461-03ED-47B3-8DD3-E91323E51810 Q42698367-4E1F05ED-5369-46DC-BD14-C4009E4D7D4E

P2860

Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.

http://www.wikidata.org/entity/Q37158146

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Induction of immunologic toler ...... improves outcome after stroke.

@en

Induction of immunologic toler ...... improves outcome after stroke.

@nl

type

label

Induction of immunologic toler ...... improves outcome after stroke.

@en

Induction of immunologic toler ...... improves outcome after stroke.

@nl

prefLabel

Induction of immunologic toler ...... improves outcome after stroke.

@en

Induction of immunologic toler ...... improves outcome after stroke.

@nl

P1433

Q37158146-168A9CC1-1C25-489A-A8C4-ECBF4859D09B

P1476

Q37158146-77CF1547-7DAA-4426-BCFC-71FB9DDFA51E

P2093

Q37158146-05E04AC4-5EDA-490F-AC71-B67E85FD09FE

Q37158146-D0D71B00-59C0-44EC-9A05-93A2E62796C8

Q37158146-F9C8A7B6-D016-4C1B-AF37-B47F68A231B6

Q37158146-FCF254F5-4C9D-4C21-9CDC-98F00812C5E1

P2860

Q37158146-06D4D906-1B0E-49C5-A91D-929AE1D49ABF

Q37158146-1644F0CC-AE9D-4254-AD8A-BF2A30E2C42D

Q37158146-1BEC3730-B70C-441D-97BE-F66FF8A36C1D

Q37158146-201643FC-426C-45C7-A167-91EF8399F74C

Q37158146-20552023-B660-4E5E-9F5B-67360F9028CC

Q37158146-2F1C27DA-F0A9-41C4-9EA7-A578EA8407DB

Q37158146-3BE2A606-C240-4005-B53A-0B8BAC671807

Q37158146-4A323F9E-600B-43E7-85CA-5CF9C33016E7

Q37158146-54382213-F601-4065-A347-8642B47F5EDD

Q37158146-6160F721-14FE-483C-883D-DB6E9B982AA5

P304

Q37158146-89134501-5FDB-4F55-BB5F-CA6629541934

P31

Q37158146-06709631-D3B9-4BCE-8EB2-DD078604C63B

P356

Q37158146-51DAF5CD-8C31-4334-95FA-147AC8BCAF70

P407

Q37158146-EC2CB753-B361-4340-B7A3-944654494057

P433

Q37158146-221F96CD-B187-4B96-A36A-346EAB358924

P478

Q37158146-EDAB59FF-834A-4B95-82F2-89DB3A94C6F7

P577

Q37158146-D5F63EDE-657F-49A2-BB1E-B9A8E927627C

P5875

Q37158146-500D86D2-B994-4D60-8E39-496AE9649105

P698

Q37158146-1CE67248-CB8F-47CC-94A2-99FF9A613A54

P932

Q37158146-774D07D5-BAF1-4405-9DFF-E5084299C27E

P356

STROKEAHA.107.501486

P1433

P1476

Induction of immunologic toler ...... improves outcome after stroke.

@en

P2093

Angela Kalil

http://www.w3.org/2001/XMLSchema#string

J Michael Gee

http://www.w3.org/2001/XMLSchema#string

Kyra J Becker

http://www.w3.org/2001/XMLSchema#string

Matthew Thullbery

http://www.w3.org/2001/XMLSchema#string

P2860

Innate immune recognition

Reversible middle cerebral artery occlusion without craniectomy in rats

Antibodies to brain antigens following stroke.

Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury

Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke.

Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.

Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation.

Myelin basic protein: a multifunctional protein.

Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia.

Sensitization to brain antigens after stroke is augmented by lipopolysaccharide.

P304

1575-1582

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/STROKEAHA.107.501486

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5529850

http://www.w3.org/2001/XMLSchema#string

P698

18323496

http://www.w3.org/2001/XMLSchema#string

P932

2668930

http://www.w3.org/2001/XMLSchema#string